Valuation
ABIOArtgen Biotech
StockMoscow ExchangeRussiaHealth care
−0.5% today · −29.9% over a year
No score: too little data.
Dividend yield 2.58%.
Ratios vs sector
Medians of Health care companies worldwide (too few in the region).
| Metric | ABIO | Sector median | vs median |
|---|---|---|---|
| P/E | — | 28.7 · n=179 | — |
| P/B | — | 4.0 · n=349 | — |
| P/S | — | 4.5 · n=339 | — |
| EV/EBIT | — | 25.8 · n=168 | — |
| Free-cash-flow yield | — | 1.5% · n=330 | — |
| Dividend yield | 2.58% | 0.00% · n=470 | — |
| Return on equity | — | −1.5% · n=361 | — |
| Return on invested capital | — | 2.3% · n=325 | — |
| Gross margin | — | 64.3% · n=244 | — |
| Net debt / EBITDA | — | 1.33 · n=173 | — |
Sector peers
The largest companies of the same sector and region.
| LLYEli Lilly & Co | 48.4 | 33.1 | — | 1.5% | 0.6% | 6/10 |
|---|---|---|---|---|---|---|
| JNJJohnson & Johnson | 41.3 | 8.2 | — | 3.1% | 1.9% | 8/10 |
| ABBVAbbVie | 50.6 | — | 27.8 | 3.6% | 2.9% | 6/10 |
| MRKMerck | 151.1 | 8.3 | — | 4.0% | 2.3% | 8/10 |
| UNHUnitedHealth | 23.1 | 3.5 | 17.5 | 6.2% | 2.2% | 10/10 |
| NVSNovartis AG | 22.5 | 6.8 | 18.8 | 5.6% | 2.4% | 10/10 |
| NOVNNovartis AG | 22.4 | 6.8 | 18.7 | 5.6% | 2.8% | 10/10 |
| AZNAstraZeneca PLC | 28.7 | 6.0 | 23.1 | 4.0% | 1.1% | 6/10 |
| AZNAstraZeneca plc | 28.6 | 6.0 | 23.1 | 4.0% | 1.7% | 8/10 |
| TMOThermo Fisher Scientific | 37.0 | 4.8 | 35.0 | 2.9% | 0.3% | 9/10 |
ratios computed by AI-Stock Invest from public filings and end-of-day prices
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.